Home LiteratureArticle Details
PMID: 5549989 Published · ppublish English Comparative Study Journal Article

Comparison of the effects of streptokinase and heparin on the early rate of resolution of major pulmonary embolism.

Canadian Medical Association journal ·Vol. 104 ·No. 6 ·1971-03-20 ·Pages 488-91 passim

Hirsh J, McDonald IG, Hale GA, O'Sullivan EF, Jelinek VM

Abstract

The extent of early resolution of major pulmonary embolism observed in 10 patients after 24 hours of treatment with heparin was compared with that seen in 17 patients after 24 hours of treatment with streptokinase. The patients in the streptokinase group also received a loading dose of heparin and were treated with heparin by continuous infusion when their thrombin time returned to normal levels. All had pulmonary hypertension. Pulmonary embolism was classified as acute in the 10 patients in the heparin group. Seven of these patients showed no angiographic change, two showed slight improvement and one showed angiographic deterioration. There was a moderate and statistically insignificant fall in mean pulmonary arterial pressure and total pulmonary resistance. Fourteen of the 17 patients who were studied before and after streptokinase were classified as acute and three as subacute progressive major pulmonary embolism. Eight showed marked angiographic improvement, four moderate and two slight angiographic improvement. There was a moderate and statistically significant fall in the mean pulmonary arterial pressure and pulmonary vascular resistance. In addition, all seven patients in whom no angiographic improvement occurred during heparin therapy showed moderate or marked angiographic improvement after a further 24 hours of treatment with streptokinase. The results strongly suggest that streptokinase therapy accelerates thrombolysis in patients with acute major pulmonary embolism.

MeSH Terms
Acute Disease Adult Aged Blood Coagulation Tests Female Hemodynamics Heparin/therapeutic use Humans Male Middle Aged Pulmonary Circulation/drug effects Pulmonary Embolism/diagnostic imaging,drug therapy Radiography Streptokinase/therapeutic use Vascular Resistance/drug effects
Chemicals
Heparin Streptokinase
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Hirsh J
McDonald I G
Hale G A
O'Sullivan E F
Jelinek V M
References (13)
13 references, click to expand
  1. Pulmonary angiography in experimental pulmonary embolism.
    Am Heart J. 1966 Oct;72(4):509-20 PMID: 5927861
  2. Observations on the fate of large pulmonary emboli.
    Am J Roentgenol Radium Ther Nucl Med. 1967 Jun;100(2):364-73 PMID: 6025207
  3. Urokinase in pulnonary embolism.
    N Engl J Med. 1967 Nov 30;277(22):1161-7 PMID: 6058603
  4. Urokinase therapy in clinical pulmonary embolism. A new thrombolytic agent.
    N Engl J Med. 1967 Nov 30;277(22):1168-73 PMID: 6058604
  5. Embolectomy for acute massive pulmonary embolism.
    Surg Gynecol Obstet. 1968 Apr;126(4):805-10 PMID: 5643162
  6. Fibrinolysis.
    Annu Rev Med. 1968;19:247-68 PMID: 4172727
  7. Heparin in the treatment of venous thrombo-embolic disease: administration, control and results.
    Med J Aust. 1968 Jul 27;2(4):153-9 PMID: 5670883
  8. Urokinase therapy in pulmonary thromboembolism.
    Am Heart J. 1968 Nov;76(5):628-37 PMID: 5698419
  9. Streptokinase therapy in acute major pulmonary embolism: effectiveness and problems.
    Br Med J. 1968 Dec 21;4(5633):729-34 PMID: 5723724
  10. Treatment of pulmonary embolism with streptokinase. A preliminary report.
    Br Med J. 1969 Mar 29;1(5647):812-5 PMID: 5774078
  11. Evaluation of a standard dosage schedule with streptokinase.
    Blood. 1970 Mar;35(3):341-9 PMID: 5437682
  12. A reappraisal of the application of the Trendelenburg operation to massive fatal embolism. Report of a successful pulmonary-artery thrombectomy using a cardiopulmonary bypass.
    N Engl J Med. 1963 Jan 24;268:171-4 PMID: 14028577
  13. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial.
    Lancet. 1960 Jun 18;1(7138):1309-12 PMID: 13797091
Article Info
Journal
Canadian Medical Association journal
Abbr.
Can Med Assoc J
ISSN
0008-4409
Published
1971-03-20
Pages
488-91 passim
Language
English
Region
Canada
NLM ID
0414110
PMCID
PMC1930899
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com